# Jewett Cameron Trading Co Ltd: financial statements, quarterly

JCTC · Nasdaq · CIK 885307 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/jctc.md) · [Financials](/companies/jctc/financials.md) · [Filings](/companies/jctc/filings.md) · [Insiders](/companies/jctc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jctc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [14.6 d](/filings/0001079973-24-001598.md) | [9.8](/filings/0001079973-25-000072.md) | [8.2](/filings/0001079973-25-000625.md) | [15.9](/filings/0001079973-25-001140.md) | [13.2 d](/filings/0001553350-25-000164.md) | [9.3](/filings/0001079973-26-000083.md) | [9.1](/filings/0001553350-26-000067.md) | [12.6](/filings/0001553350-26-000097.md) | [10.4 d](/filings/0001553350-25-000164.md) | [8.7](/filings/0001079973-26-000083.md) | [10.5](/filings/0001553350-26-000067.md) | [9.9](/filings/0001553350-26-000097.md) |
| Cost of revenue | $m | [11.6 d](/filings/0001079973-24-001598.md) | [7.8](/filings/0001079973-25-000072.md) | [6.2](/filings/0001079973-25-000625.md) | [12.9](/filings/0001079973-25-001140.md) | [11.3 d](/filings/0001553350-25-000164.md) | [7.6](/filings/0001079973-26-000083.md) | [7.2](/filings/0001553350-26-000067.md) | [10.7](/filings/0001553350-26-000097.md) | [9.5 d](/filings/0001553350-25-000164.md) | [9.7](/filings/0001079973-26-000083.md) | [8.9](/filings/0001553350-26-000067.md) | [8.1](/filings/0001553350-26-000097.md) |
| Gross profit | $m | [3.1 d](/filings/0001079973-24-001598.md) | [2.0](/filings/0001079973-25-000072.md) | [2.1](/filings/0001079973-25-000625.md) | [3.0](/filings/0001079973-25-001140.md) | [1.9 d](/filings/0001553350-25-000164.md) | [1.7](/filings/0001079973-26-000083.md) | [1.8](/filings/0001553350-26-000067.md) | [1.9](/filings/0001553350-26-000097.md) | [0.9 d](/filings/0001553350-25-000164.md) | [(1.1)](/filings/0001079973-26-000083.md) | [1.6](/filings/0001553350-26-000067.md) | [1.8](/filings/0001553350-26-000097.md) |
| Selling, general and administrative | $m | [1.1 d](/filings/0001079973-24-001598.md) | [0.9](/filings/0001079973-25-000072.md) | [1.0](/filings/0001079973-25-000625.md) | [1.0](/filings/0001079973-25-001140.md) | [0.9 d](/filings/0001553350-25-000164.md) | [0.8](/filings/0001079973-26-000083.md) | [0.9](/filings/0001553350-26-000067.md) | [1.0](/filings/0001553350-26-000097.md) | [1.1 d](/filings/0001553350-25-000164.md) | [1.4](/filings/0001079973-26-000083.md) | [1.4](/filings/0001553350-26-000067.md) | [1.3](/filings/0001553350-26-000097.md) |
| Operating income | $m | [0.4 d](/filings/0001079973-24-001598.md) | [(0.8)](/filings/0001079973-25-000072.md) | [(0.7)](/filings/0001079973-25-000625.md) | [0.1](/filings/0001079973-25-001140.md) | [(0.3) d](/filings/0001553350-25-000164.md) | [(0.9)](/filings/0001079973-26-000083.md) | [(0.8)](/filings/0001553350-26-000067.md) | [(0.7)](/filings/0001553350-26-000097.md) | [(1.4) d](/filings/0001553350-25-000164.md) | [(3.8)](/filings/0001079973-26-000083.md) | [(1.1)](/filings/0001553350-26-000067.md) | [(0.8)](/filings/0001553350-26-000097.md) |
| Interest expense | $m | [0.1 d](/filings/0001079973-23-001665.md) | [0.0](/filings/0001079973-24-000069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3 d](/filings/0001079973-24-001598.md) | [0.5](/filings/0001079973-25-000072.md) | [(0.2)](/filings/0001079973-25-000625.md) | [(0.1)](/filings/0001079973-25-001140.md) | [(0.1) d](/filings/0001553350-25-000164.md) | [(0.2)](/filings/0001079973-26-000083.md) | [(0.2)](/filings/0001553350-26-000067.md) | [(0.1)](/filings/0001553350-26-000097.md) | [0.6 d](/filings/0001553350-25-000164.md) | [0.0](/filings/0001079973-26-000083.md) | [(0.0)](/filings/0001553350-26-000067.md) | [(0.0)](/filings/0001553350-26-000097.md) |
| Net income | $m | [0.3](/filings/0001079973-24-001053.md) | [1.3](/filings/0001079973-25-000072.md) | [(0.5)](/filings/0001079973-25-000625.md) | [0.2](/filings/0001079973-25-001140.md) | [(0.2)](/filings/0001079973-25-001140.md) | [(0.7)](/filings/0001079973-26-000083.md) | [(0.6)](/filings/0001553350-26-000067.md) | [(0.6)](/filings/0001553350-26-000097.md) | [(2.2)](/filings/0001553350-26-000097.md) | [(3.9)](/filings/0001079973-26-000083.md) | [(1.2)](/filings/0001553350-26-000067.md) | [(0.8)](/filings/0001553350-26-000097.md) |
| Diluted EPS | $ per share | not reported | [0.37](/filings/0001079973-25-000072.md) | [(0.15)](/filings/0001079973-25-000625.md) | [0.04](/filings/0001079973-25-001140.md) | not reported | [(0.19)](/filings/0001079973-26-000083.md) | [(0.16)](/filings/0001553350-26-000067.md) | [(0.18)](/filings/0001553350-26-000097.md) | not reported | [(1.12)](/filings/0001079973-26-000083.md) | [(0.35)](/filings/0001553350-26-000067.md) | [(0.23)](/filings/0001553350-26-000097.md) |
| Basic EPS | $ per share | not reported | [0.37](/filings/0001079973-25-000072.md) | [(0.15)](/filings/0001079973-25-000625.md) | [0.04](/filings/0001079973-25-001140.md) | not reported | [(0.19)](/filings/0001079973-26-000083.md) | [(0.16)](/filings/0001553350-26-000067.md) | [(0.18)](/filings/0001553350-26-000097.md) | not reported | [(1.12)](/filings/0001079973-26-000083.md) | [(0.35)](/filings/0001553350-26-000067.md) | [(0.23)](/filings/0001553350-26-000097.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001079973-24-001598.md) | [3.6](/filings/0001079973-24-000069.md) | [1.1](/filings/0001079973-24-000549.md) | [1.1](/filings/0001079973-24-001053.md) | [4.9](/filings/0001553350-25-000164.md) | [3.0](/filings/0001079973-25-000072.md) | [0.4](/filings/0001079973-25-000625.md) | [1.2](/filings/0001079973-25-001140.md) | [0.2](/filings/0001553350-26-000097.md) | [1.0](/filings/0001079973-26-000083.md) | [0.5](/filings/0001553350-26-000067.md) | [1.1](/filings/0001553350-26-000097.md) |
| Current assets | $m | [24.7](/filings/0001079973-24-001598.md) | [25.1](/filings/0001079973-24-000069.md) | [24.2](/filings/0001079973-24-000549.md) | [23.3](/filings/0001079973-24-001053.md) | [23.2](/filings/0001553350-25-000164.md) | [22.3](/filings/0001079973-25-000072.md) | [23.0](/filings/0001079973-25-000625.md) | [24.5](/filings/0001079973-25-001140.md) | [21.7](/filings/0001553350-26-000097.md) | [20.0](/filings/0001079973-26-000083.md) | [18.7](/filings/0001553350-26-000067.md) | [15.3](/filings/0001553350-26-000097.md) |
| Total assets | $m | [29.8](/filings/0001079973-24-001598.md) | [29.9](/filings/0001079973-24-000069.md) | [29.0](/filings/0001079973-24-000549.md) | [28.3](/filings/0001079973-24-001053.md) | [27.5](/filings/0001553350-25-000164.md) | [26.7](/filings/0001079973-25-000072.md) | [27.6](/filings/0001079973-25-000625.md) | [29.2](/filings/0001079973-25-001140.md) | [25.5](/filings/0001553350-26-000097.md) | [23.2](/filings/0001079973-26-000083.md) | [21.9](/filings/0001553350-26-000067.md) | [18.4](/filings/0001553350-26-000097.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [5.7](/filings/0001079973-24-001598.md) | [4.5](/filings/0001079973-24-000069.md) | [4.1](/filings/0001079973-24-000549.md) | [3.3](/filings/0001079973-24-001053.md) | [2.6](/filings/0001553350-25-000164.md) | [2.6](/filings/0001079973-25-000072.md) | [3.9](/filings/0001079973-25-000625.md) | [6.2](/filings/0001079973-25-001140.md) | [4.7](/filings/0001553350-26-000097.md) | [6.4](/filings/0001079973-26-000083.md) | [6.3](/filings/0001553350-26-000067.md) | [3.6](/filings/0001553350-26-000097.md) |
| Shareholders' equity | $m | [24.1](/filings/0001553350-25-000164.md) | [25.4](/filings/0001079973-25-000072.md) | [24.9](/filings/0001079973-25-000625.md) | [25.0](/filings/0001079973-25-001140.md) | [24.9](/filings/0001553350-26-000097.md) | [24.2](/filings/0001079973-26-000083.md) | [23.7](/filings/0001553350-26-000067.md) | [23.0](/filings/0001553350-26-000097.md) | [20.8](/filings/0001553350-26-000097.md) | [16.8](/filings/0001079973-26-000083.md) | [15.6](/filings/0001553350-26-000067.md) | [14.8](/filings/0001553350-26-000097.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,046 d](/filings/0001079973-24-001598.md) | [4,632](/filings/0001079973-25-000072.md) | [(2,412) d](/filings/0001079973-25-000625.md) | [14.5 d](/filings/0001079973-25-001140.md) | [3,795 d](/filings/0001553350-25-000164.md) | [(1,777)](/filings/0001079973-26-000083.md) | [(2,584) d](/filings/0001553350-26-000067.md) | [(1,616) d](/filings/0001553350-26-000097.md) | [(636) d](/filings/0001553350-25-000164.md) | [(1,321)](/filings/0001079973-26-000083.md) | [(532) d](/filings/0001553350-26-000067.md) | [3,464 d](/filings/0001553350-26-000097.md) |
| Capital expenditure | $k | [8.2 d](/filings/0001079973-24-001598.md) | [0.0](/filings/0001079973-25-000072.md) | [0.0 d](/filings/0001079973-25-000625.md) | [111 d](/filings/0001079973-25-001140.md) | [0.0 d](/filings/0001553350-25-000164.md) | [37.3](/filings/0001079973-26-000083.md) | [19.3 d](/filings/0001553350-26-000067.md) | [36.7 d](/filings/0001553350-26-000097.md) | [21.6 d](/filings/0001553350-25-000164.md) | [0.0](/filings/0001079973-26-000083.md) | [0.0 d](/filings/0001553350-26-000067.md) | [0.0 d](/filings/0001553350-26-000097.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,496](/filings/0001079973-24-000069.md) | [3,499](/filings/0001079973-24-000549.md) | [3,499](/filings/0001079973-24-001053.md) | [3,499](/filings/0001079973-25-000072.md) | [3,504](/filings/0001079973-25-000625.md) | [3,505](/filings/0001079973-25-001140.md) | [3,505](/filings/0001079973-26-000083.md) | [3,515](/filings/0001553350-26-000067.md) | [3,518](/filings/0001553350-26-000097.md) | [3,518](/filings/0001079973-26-000083.md) | [3,520](/filings/0001553350-26-000067.md) | [3,520](/filings/0001553350-26-000097.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,520,113 at 2026-07-14, from the cover of the [10-Q filed 2026-07-14](/filings/0001553350-26-000097.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.